The host response to calcium silicate ceramic coatings is not always favorable because of their high dissolution rates, leading to high pH within the surrounding physiological environment. Recently, a zinc-incorporated calcium silicate-based ceramic Ca 2 ZnSi 2 O 7 coating, developed on a Ti-6Al-4V substrate using plasma-spray technology, was found to exhibit improved chemical stability and biocompatibility. This study aimed to investigate and compare the in vitro response of osteoblastic MC3T3-E1 cells cultured on Ca 2 ZnSi 2 O 7 coating, CaSiO 3 coating, and uncoated Ti-6Al-4V titanium control at cellular and molecular level. Our results showed Ca 2 ZnSi 2 O 7 coating enhanced MC3T3-E1 cell attachment, proliferation, and differentiation compared to CaSiO 3 coating and control. In addition, Ca 2 ZnSi 2 O 7 coating increased mRNA levels of osteoblast-related genes (alkaline phosphatase, procollagen a1(I), osteocalcin), insulin-like growth factor-I (IGF-I), and transforming growth factor-b1 (TGF-b1). The in vivo osteoconductive properties of Ca 2 ZnSi 2 O 7 coating, compared to CaSiO 3 coating and control, was investigated using a rabbit femur defect model. Histological and histomorphometrical analysis demonstrated new bone formation in direct contact with the Ca 2 ZnSi 2 O 7 coating surface in absence of fibrous tissue and higher bone-implant contact rate (BIC) in the Ca 2 ZnSi 2 O 7 coating group, indicating better biocompatibility and faster osseointegration than CaSiO 3 coated and control implants. These results indicate Ca 2 ZnSi 2 O 7 coated implants have applications in bone tissue regeneration, since they are biocompatible and able to osseointegrate with host bone.
Introduction
In recent years, calcium silicate-based ceramics have become more promising as potential implant biomaterials for bone tissue engineering due to their bioactive and biocompatible properties [1] [2] [3] . Despite the beneficial influence on bone response, wellknown drawbacks associated with this material exist, such as poor mechanical properties, which limit the scope of its clinical application [4] [5] [6] . However, these limitations can be overcome by surface-modification techniques [7, 8] . The bioactive ceramic coating would confer adequate bioactivity to the surface of the implant, preventing direct contact between the substrate and surrounding bone tissue, thus reducing release of problematic ions from the metallic substrate.
Several coating techniques have been developed and include flame spraying, sputtering, electrophoretic coating, hot isostatic pressing and solution coating [9] . Each approach has its advantages and disadvantages; however, plasma-spraying has shown the most promise as a coating method. In fact, plasmaspraying is reported as the method of choice for coating CaSiO 3 and Ca 2 SiO 4 onto metal substrates, both of which have been used clinically to enhance bioactivity and bonding strength with titanium alloy in comparison to HA coating [10] . However, major limitations of calcium silicate coatings include deleterious biological effects due to their high dissolution rate and induction of high pH within the surrounding tissues, which limits further their biomedical application [5] .
Recently, ion-modification of Ca-Si-based ceramics has been developed to improve their chemical stability and biomedical properties and includes divalent (Mg [11] , Zn [12, 13] and Sr [14] ) and tetravalent (Ti [5] and Zr [15] ) modification. Moreover, Ti and Zr-incorporated Ca-Si-based ceramics have been used as stable coatings that improve biomedical properties compared with calcium silicate coatings [16, 17] . However, Zn-modified calcium silicate (Ca 2 ZnSi 2 O 7 ) ceramic coatings have not been fully investigated to date. It is well established that zinc, an essential trace element, plays an important role in various physiological processes [18] . Zn has been shown to have a stimulatory effect on bone formation and an inhibitory or biphasic effect on osteoclastic bone resorption [19] . Zinc deficiency results in the arrest of bone growth, bone development, and the overall maintenance of bone health [20, 21] . This indicates Ca 2 ZnSi 2 O 7 is an interesting biomaterial coating that warrants further investigation. In our previous work, Zn was selected for incorporation into a Ca-Si system to form hardystonite (Ca 2 ZnSi 2 O 7 ), which was used as a feedstock coating on the Ti-6Al-4V substrate using plasma-spray technology. Ca 2 ZnSi 2 O 7 coating exhibited chemically stable (low dissolution) and good bioactivity in comparison with CaSiO 3 coating [22] . In the present study, we investigate how Ca 2 ZnSi 2 O 7 coating affects adhesion, morphology, orientation, proliferation and osteoblast differentiation of MC3T3-E1 osteoprogenitor cells (Fig. 1a) . The in vivo osseointegration potential of Ca 2 ZnSi 2 O 7 coating was also assessed using a rabbit femur defect implantation model (Fig. 1b) .
Materials and Methods

Specimen Preparation and Characterization
Ca 2 ZnSi 2 O 7 powders and coatings were prepared according to methods described previously [22] substrates with dimensions of 1061062 mm and ø1061 mm, for in vitro cell culture and in vivo study respectively. The atmosphere plasma spray (APS) system (Sulzer Metco, Switzerland) was used to fabricate all coatings. The thickness of the coating was approximately 170 mm. Before plasma-spraying, substrates were ultrasonically cleaned in acetone and grit-blasted using corundum sand of F60 grade. CaSiO 3 coatings were prepared using the same conditions as the control. Samples were ultrasonically cleaned and sterilized in acetone, ethanol and distilled water for 10 min.
The phase composition, surface morphology, surface roughness (Ra) and bonding strength of the Ca 2 ZnSi 2 O 7 coating was characterized in our previous work [22] .
In vitro Testing
Cell culture. The osteoblast-like cell line, MC3T3-E1, was obtained from the Chinese Academy of Sciences Cell Bank. Cells were cultured in culture plates containing alpha-minimal essential medium (a-MEM, Gibco BRL, Invitrogen, Life Technologies, USA) supplemented with 10% (v/v) fetal bovine serum (FBS) and 1% (v/v) of a 100 U/ml penicillin and 100 mg/ml streptomycin solution (Gibco BRL, respectively). Cells were incubated at 37uC in the presence of 5% CO 2 . On reaching 80% confluence, cells were detached every 2-3 days using 0.25% trypsin/EDTA solution (Gibco BRL).
Cell attachment and morphology. MC3T3-E1 cells were seeded onto uncoated Ti-6Al-4V titanium (control), CaSiO 3 . Cells were incubated in a-MEM culture medium supplemented with 10% FBS at 37uC in 5% CO 2 for 24 h. Samples were rinsed with PBS (pH 7.4) to remove non-adherent cells and fixed in 4% paraformaldehyde for 1 h. Cells were subsequently rinsed with PBS buffer containing 4% (w/v) sucrose and post-fixed in 1% osmium tetroxide in PBS, followed by sequential dehydration in an ethanol series of 30%, 50%, 70%, 90%, 95% and 100% for 5 minutes in each concentration. Specimens were sputter-coated with gold and the morphological characteristics of the attached cells were determined using scanning electron microscope (SEM, S-4800, Hitachi, Japan).
Cell proliferation. Cell proliferation was measured using a standard methyl thiazolyl tetrazolium (MTT) assay (SigmaAldrich, Saint Louis, MO, n = 6 for each sample). MC3T3-E1 cells were cultured on control, CaSiO 3 and Ca 2 ZnSi 2 O 7 coated substrates placed individually in a 24-well culture plate at a density of 1610 4 cells/cm 2 and allowed to grow for 1, 4, 7 and 14 days. At the specified time-points, the substrates were washed in PBS and transferred to another new 24-well plate. MTT stock solution (10% of total volume) was added to 24-well plates containing the coatings and incubated for 4 h at 37uC and 5% CO 2 . Medium was withdrawn and dimethyl sulphoxide (Sigma-Aldrich) was added to each well to dissolve the formazan dye crystals. 100 ul of the reacted reagent from each well was transferred to 96-well plates and the absorbance measured using a microplate reader (SPECTRA MAX PLUS 384 MK3, Thermo Fisher Scientific, Waltham, MA, USA) at a wavelength of 490 nm.
Cell differentiation and mineralization. MC3T3-E1 cell osteoblast differentiation and mineralization were determined using cells (1610 4 cells/cm 2 ) cultured in triplicate (n = 3) on each coating group in differentiation medium comprising a-MEM medium supplemented with 50 mg/ml ascorbic acid (SigmaAldrich) and 10 mM b-glycerophosphate (Sigma-Aldrich). Cell differentiation and mineralization were characterized from alkaline phosphatase (ALP) activity and Osteocalcin (OC) secretion. Concentrations of ALP and OC were individually determined using ELISA kits (R&D Systems, Minneapolis, MN, USA) as described below.
Quantitative measurement of ALP activity. MC3T3-E1 cells were cultured on control, CaSiO 3 and Ca 2 ZnSi 2 O 7 coated substrates in differentiation medium for 1, 4, 7 and 14 days. ALP activity was measured using stable p-nitrophenol phosphate substrate. At each time point, culture medium was removed by decantation and cells were washed with PBS and harvested in 1 ml universal ALP buffer (100 mM citric acid, 100 mM KH 2 PO 4 , 100 mM sodium tetraborate.10 H 2 O, 100 mM Tris, 100 mM KCl; pH 11). Cells were sonicated twice for 20 sec and centrifuged at 3000 rpm for 5 min at 4uC. ALP activity in the supernatants was determined following addition of p-nitrophenyl phosphate substrate and the reaction was stopped using 100 ml of 0.1 N NaOH. The optical density was measured at 405 nm using a microplate reader (SPECTRA MAX PLUS 384 MK3, Thermo). The ALP activity was calculated from a standard curve after normalization to total protein content, which was measured using the Bradford protein assay kit (Pierce, Rockford, IL, USA). ALP experiments were repeated twice with n = 3 for each substrate.
Quantitative measurement of OC secretion. MC3T3-E1 cells were cultured on control, CaSiO 3 and Ca 2 ZnSi 2 O 7 coated substrates in differentiation medium for 1, 7, 14 and 21 days. Quantitative levels of OC secreted into the culture medium were determined using an enzyme-linked immunoassay (ELISA) kit (R&D) following the manufacturer's instructions.
Quantitative reverse transcription-PCR (qRT-PCR).
Total RNA was isolated from MC3T3-E1 cells on each coated substrate using Trizol reagent (Fermentas, Maryland, NY, USA). First-strand cDNA synthesis was carried out using Superscript III reverse transcriptase (Invitrogen, Carlsbad, CA, USA) for 60 min at 50uC. Quantitative RT-PCR for MC3T3-E1 cell osteoblast-related genes of alkaline phosphatase (ALP), procollagen a1(I) (Col a1(I)), osteocalcin (OC)and growth factors gene of insulin-like growth factor-I (IGF-I) and transforming growth factor-b1 (TGF-b1), was performed using the ABI PRISMs 7000 Sequence Detection System (Applied Biosystems, Foster City,CA, USA). The amount of target gene transcript in each sample was determined using SYBRH Premix Ex Taq TM II (Takara, Kyoto, Japan) in a final volume of 20 ml containing the same amount of RT product (50 ng cDNA), 10 ml of 26SYBRH Premix Ex Taq TM II and 0.8 ml of 10 mM forward and reverse primers. Primers for the selected genes are listed in Table 1 
In vivo Analysis
Surgical procedure. Total nine White New Zealand rabbits (obtained from Shanghai Jiao Tong University, Laboratory Animal Center, male, 2-2.5 kg body weight) were randomly divided into 3 groups. The use of animals and the experimental protocols was approved by the Institutional Animal Welfare Committee of Shanghai Jiao Tong University. A total of six cylindrical implants of approximately 1 mm in diameter and 1 cm in length were implanted into the femur of each rabbit. Three implants were inserted into the femur of the left hind leg and another three into the femur of the right hind leg. A schedule was prepared to ensure equal placement of the three implant types within each of the six femoral sites and one of each implant types placed into each femur. Rabbits were anesthetized by injecting 3% Nembutal (30 mg/kg) via the ear vein and a longitudinal incision was made by scalpel in the rabbit femur under rigorous aseptic conditions. Circular holes, 1 mm diameter by 1.0 cm deep, were drilled using a surgical electronic drill and thoroughly rinsed with physiological saline to remove shards of bone. Implants of Ti-6Al-4V (control), CaSiO 3 -coated Ti-6Al-4V and Ca 2 ZnSi 2 O 7 -coated Ti-6Al-4V were used in this study. Before insertion of implants, blood was removed using sterile cotton balls and the holes were manually filled with implants as tightly as possible. The wound was sutured with nylon thread. Rabbits were sacrificed 1.5 month after implantation.
Specimen preparation. After sacrifice, Excised specimens were fixed in 4% paraformaldehyde for 3 days, dehydrated in a series of ethanol solutions (70, 80, 90, 95 and 100%) and embedded in polymethylmethacrylate resin. Undecalcified sections with a thickness of 100 mm were cut using a saw microtome (Leica ST1600) and stained with trinitrophenolfuchsin prior to histological analysis. A minimum of 6 sections were made from each implant and used for descriptive and morphometric analyses.
Histology and histomorphometry. Histological observation and histomorphometrical analysis of the sections were performed under a biologic fluorescence microscope (Olympus BX-60). The microscopic images of the sections were digitized and analyzed using an image-analyzing software (KS400). The bone-implant contact rate (BIC) was used as the index of osseointegration, equal to the surface length contact of the implant with the bone/the overall surface length of implant inserted into the bone.
Statistical Analysis
For statistical analysis, first Levene's test was performed to determine the homogeneity of variance for all the data, and then one way analysis of variance followed by Tukey or Tamhane's T2 post-hoc test for multiple comparison was performed for the comparisons between different groups. SPSS 17.0 program was employed for all statistical analysis and differences were considered significant if p,0.05. All data were expressed as a mean 6 standard deviation (SD).
Results
Cell Attachment and Morphology
MC3T3-E1 cell attachment and morphology on control, CaSiO 3 and Ca 2 ZnSi 2 O 7 coated substrates were examined using SEM (Fig. 2) . After 24 h of culture, MC3T3-E1 cells were found to attach to all tested samples surface. The cells displayed a trianglelike morphology on the surface of the titanium control (Fig. 2a, b) but appeared spindle-like on the surface of both the Ca 2 ZnSi 2 O 7 (Fig. 2e, f) and CaSiO 3 (Fig. 2c, d ) coated substrates. A greater number of cells had cytoplasmic extensions, which were longer in protrusion, on the Ca 2 ZnSi 2 O 7 coated surface in comparison to CaSiO 3 and control.
Cell Proliferation
MC3T3-E1 cell proliferation on control, CaSiO 3 and Ca 2 ZnSi 2 O 7 coated substrates was determined using an MTT assay. A statistically significant increase in cell proliferation was measured on all samples with increasing culture time (Fig. 3) . Cell proliferation was increased on days 1, 4, 7 and 14 on Ca 2 ZnSi 2 O 7 coated substrate compared to either CaSiO 3 coated substrate or control (p,0.05).
Cell Differentiation and Mineralization
Cell differentiation from pre-osteoblasts to osteoblasts revealed osteogenic functioning of MC3T3-E1 cells on all substrates. ALP assays were performed on MC3T3-E1 cells cultured on control, CaSiO 3 and Ca 2 ZnSi 2 O 7 coated substrates at various time points. ALP activity presented a similar profile for all samples, with increased activity throughout the culture duration (Fig. 4 ). For all conditions tested, there was no significant difference in ALP activity between days 1 and 4, after which levels rapidly increased up to day 14. ALP activity within cells incubated on Ca 2 ZnSi 2 O 7 coating increased above those on the CaSiO 3 coating and control (p,0.05 for CaSiO 3 coating and control at day 7, 14) . Results therefore indicate that Ca 2 ZnSi 2 O 7 coating can promote cell maturation as reflected by increased ALP activity.
Levels of the differentiation marker, OC, were investigated at days 1, 7, 14 and 21 of culture. As shown in Fig. 5 , no significant difference in OC levels were found in MC3T3-E1 cells cultured on 
Osteoblast-related Gene Expression
MC3T3-E1 cells were cultured for 1, 2 and 3 weeks on control, CaSiO 3 and Ca 2 ZnSi 2 O 7 coatings and expression of typical bonerelated genes was examined using qRT-PCR (Fig. 6) . ALP mRNA expression levels (Fig. 6a ) in MC3T3 cells cultured on Ca 2 ZnSi 2 O 7 coating steadily increased with time and were significantly higher (p,0.05) compared to cells cultured on CaSiO 3 coating and control. These results are consistent with the previous ALP activity findings. procollagen a1(I) mRNA expression (Fig. 6b) decreased with time for all samples, but levels were significantly higher in cells on Ca 2 ZnSi 2 O 7 coating in comparison to those on CaSiO 3 coating and control (p,0.05 for CaSiO 3 coating and control at week 1; p,0.05 for control alone at week 2). Osteocalcin mRNA expression (Fig. 6c) increased slightly over two weeks for all samples, after which levels rapidly increased up to week 3. In comparison to CaSiO 3 coating and control, osteocalcin mRNA levels in cells grown on Ca 2 ZnSi 2 O 7 coating were significantly increased (p,0.05 for CaSiO 3 coating and control). IGF-I mRNA expression (Fig. 6d) increased with time for all samples although 
In vivo Analysis
Histology. The excellent in vitro properties of Ca 2 ZnSi 2 O 7 coating led to analysis of its in vivo biocompatible properties following implantation into a rabbit femur defect model. No inflammation or other implant-associated complications were observed macroscopically or microscopically in any of the histopathology sections for the implanted Ca 2 ZnSi 2 O 7 coatings throughout the experimental periods. After 1.5 month of implantation, new bone was primarily observed at the Ca 2 ZnSi 2 O 7 coating periphery with direct contact to the implant surface in absence of a connective tissue layer (Fig. 7g-i) . In contrast, fibrous tissue was clearly seen around the surface of the CaSiO 3 coating (Fig. 7d-f ) and control (Fig. 7a-c) , resulting in markedly reduced bone-implant contact. New bone formation was sparse around these two implants.
Histomorphometry. The results of the histomorphometric measures are shown in Fig. 8 
Discussion
It is well-known that biomaterial physicochemical characteristics are important in tissue engineering because of their direct effect on cellular response and ultimately tissue regeneration [23] . Surface modifications have been applied to metallic biomaterials in order to improve their wear properties, corrosion resistance, and biocompatibility [24, 25] . Our previous studies have shown the Zn-modified calcium silicate (Ca 2 ZnSi 2 O 7 ) ceramic coating exhibits significantly improved stability in physiological solution and good bioactivity, as well as high bonding strength with the titanium alloy substrate [22] . We therefore conducted a more detailed study to examine and compare the in vitro and in vivo response of osteoblast-like MC3T3-E1 cells cultured on uncoated Ti-6Al-4V titanium (control), CaSiO 3 coated and Ca 2 ZnSi 2 O 7 coated substrates and investigate their capacity to conduct osteoregeneration after implantation into a rabbit femur defect model.
Biomaterial surface specifications can influence adsorption of biological molecules and, in the second stage, adsorption of cells [26] . Hence, adequate adhesion and spreading of cells are prerequisite for the interaction of cells with their substrate, which will determine subsequent cellular activities including proliferation and differentiation. Investigation into cell attachment found that MC3T3-E1 cells adhere to Ca 2 ZnSi 2 O 7 coating with greater spread and number of filopodia projections anchored to the surface than those adhering to CaSiO 3 coating or control, which indicates that Ca 2 ZnSi 2 O 7 coating has a good bioactive surface favorable for cell adhesion and growth with good biocompatibility.
Ideally bioactive biomaterials need to interact actively with cells and stimulate cell growth [27] . MTT assay showed MC3T3-E1 cells could proliferate on all three samples. Furthermore, the proliferation ratio on Ca 2 ZnSi 2 O 7 ceramic coating was higher than that on CaSiO 3 coating or control at all time points, suggesting Ca 2 ZnSi 2 O 7 coating modulates cell proliferation activity. Besides proliferation, the ability of preosteoblasts to differentiate on the biomaterials is an important stage that occurs before bone mineralization. ALP was used as a marker for early and mid-stages of osteoblast maturation and bone matrix production [28] [29] [30] . In our study, MC3T3-E1 cell ALP activity on Ca 2 ZnSi 2 O 7 coating exhibited higher levels of expression than on CaSiO 3 coating or control from day 7. This is in accordance with the results of ALP gene regulation, indicating Ca 2 ZnSi 2 O 7 coating might possess a greater ability to stimulate preosteoblast differentiation compared to CaSiO 3 coating and control. As expected, Zn ions appear to be the relevant inducers of ALP activity, since ALP is a Zn-dependent enzyme [31] . OC is secreted solely by osteoblasts and thought to play a role in cell mineralization and calcium ion homeostasis [32] . Our results show that Ca 2 ZnSi 2 O 7 coating indeed markedly raises levels of OC over control levels at later periods in culture, which indicates their higher maturation state at this period. Further investigation into OC expression found mRNA levels followed a similar trend to OC levels, indicating that Zn-modified calcium silicate (Ca 2 ZnSi 2 O 7 ) ceramic coating possesses a greater ability to promote osteoblast mineralization of MC3T3-E1 cells compared to CaSiO 3 coating or control. Our findings are consistent with data reported by other research groups. Chesters [33] and Cousins [34] report that zinc is an essential trace element involved in diverse metabolic and cellular signaling pathways and is involved in the modulation of gene expression for proteins involved in bone formation. Ito et al also report that incorporation of zinc into calcium phosphate cement significantly promotes preosteoblast proliferation and differentiation in vitro [35] [36] [37] . More recently, Kwun et al. suggest zinc is involved in regulating the transcription of preosteoblast differentiation genes, such as Col-I, ALP, osteopontin and OC [38] . Hence, Zn is considered to be one promising agent for enhancing the bone-forming ability of implant materials, which can be achieved by controlling the release of Zn ions. Our studies suggest that Zn ions released form Ca 2 ZnSi 2 O 7 coatings might play an important role in MC3T3-E1 cell proliferation and differentiation.
In the present study, MC3T3-E1 cells were used to investigate the influence of Ca 2 ZnSi 2 O 7 coating on regulation of osteoblastassociated genes: ALP, Col a1(I) and OC by qRT-PCR. These genes are major phenotypic markers for preosteoblast differentiation during bone formation [39] . Col-I is the most abundant protein synthesized by active osteoblasts and is essential to mineral deposition, so its expression represents the start of osteoblast differentiation [40] . Col a1(I) mRNA expression (early marker, major extracellular collagenous protein for organic matrix formation) was upregulated in cells on Ca 2 ZnSi 2 O 7 coating compared to CaSiO 3 coating and control. The increase was pronounced during the early stage time points, which represent the beginning of osteoblast differentiation. Similar results were observed by Ehara et al, who found that calcium phosphate compounds cultured with MC3T3-E1 cells accelerated osteoblast differentiation in the early phase and promoted matrix production [41] . The results of this study demonstrate that at molecular level, osteoblast bone marker gene expression (ALP, Col a1(I), OC) on Ca 2 ZnSi 2 O 7 coating is up-regulated, indicating Ca 2 ZnSi 2 O 7 as Growth factors have become an important component for tissue engineering and regenerative medicine [42] [43] [44] . In particular, IGF-I and TGF-b1 have great significance in bone tissue engineering [45] . IGF-I has been implicated as a regulator of osteoblast abundance to maintain bone matrix by enhancing osteoblast matrix production [46] and regulating osteoclast bone resorption [47] . TGF-b1 is considered another important regulator of osteoblast and osteoclast activity [48] . It is activated by resorbing osteoclasts which in turn attenuates further bone resorption by impairing osteoclastogenesis and promoting bone formation through chemotactic attraction of osteoblasts, enhancement of osteoblast proliferation and the early stages of differentiation with production of ECM proteins (including Col-I, osteopontin, OC) [49] . However, the effect of biomaterials on gene expressions of these factors in osteoblast cells has not been fully clarified. This study investigated mRNA expressions of IGF-I and TGF-b1 on the control, CaSiO 3 and Ca 2 ZnSi 2 O 7 coated substrates using qRT-PCR. We found that culture on Ca 2 ZnSi 2 O 7 coating caused a significant increase in IGF-I and TGF-b1 mRNA expression in MC3T3-E1 cells, both of which are involved in the stimulation of bone formation and cell proliferation within osteoblast cells. Yamaguchi et al. also report that culture with zinc stimulates protein production of IGF-I, TGF-b1 or osteocalcin in osteoblastic MC3T3-E1 cells [50] .
All the results obtained in vitro indicate that Ca 2 ZnSi 2 O 7 coating is more favorable to the cellular activities of MC3T3-E1 cells, indicating that this coating might be suitable for bone regeneration and tissue engineering compared to CaSiO 3 coating and control. The behavior of the bone tissue around Ca 2 ZnSi 2 O 7 coating following implantation in rabbit femurs was also investigated. We found new bone was formed and in direct contact with the implants after 1.5 month of Ca 2 ZnSi 2 O 7 coating implantation, in absence of fibrous tissue infiltration around the implant. In contrast, a wide band of fibrous tissue was clearly seen around the surface of the CaSiO 3 coating and control. These observations were in line with the histomorphometrical data. Our results showed the direct bone contact with the implant (BIC) of Ca 2 ZnSi 2 O 7 coating group was significantly greater than that for CaSiO 3 coating and control after 1.5 month implantation. So, we concluded that Ca 2 ZnSi 2 O 7 coatings have better bone integration properties after implantation, compared to CaSiO 3 coating and control. This is consistent with the results obtained by Zreiqat et al., who observed that the incorporation of Sr and Zn into their Ca-Si system induced in vivo osteoconductivity at 3 and 6 weeks following implantation in tibial bone defects in rats [51] .
Conclusions
Plasma-sprayed Ca 2 ZnSi 2 O 7 coating enhanced MC3T3-E1 cell attachment, proliferation, differentiation and up-regulated bone marker gene expression of ALP, Col a1(I) and OC and growth factors genes of IGF-I and TGF-b1, compared to CaSiO 3 coating and control. The in vivo study demonstrates further efficacy of Ca 2 ZnSi 2 O 7 coating in modulating bone formation around the implant and enhancement of osseointegration in absence of fibrous tissue response. In conclusion, the biological properties observed for the investigated Ca 2 ZnSi 2 O 7 coating strongly suggest it is a good candidate for orthopedic and dental implant fixation.
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